We are live on ! Find out more
HGEN

HUMANIGEN, INC.

Delisted

HGEN was delisted on the 25th of July, 2023.

48 hedge funds and large institutions have $858K invested in HUMANIGEN, INC. in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more call options, than puts

Call options by funds: $25K | Put options by funds: $12K

9% less funds holding

Funds holding: 5348 (-5)

24% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 17

36% less capital invested

Capital invested by funds: $1.34M → $858K (-$479K)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

Holders
48
Holders Change
-5
Holders Change %
-9.43%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
13
Reduced
17
Closed
10
Calls
$25K
Puts
$12K
Net Calls
+$13K
Net Calls Change
-$12K
Name Holding Trade Value Shares
Change
Change in
Stake
LP
51
LMR Partners
United Kingdom
-$3K -17,406 Closed
PA
52
Pinnacle Associates
New York
-$2K -12,500 Closed
Commonwealth Equity Services
53
Commonwealth Equity Services
Massachusetts
-$1K -10,690 Closed
CG
54
Cutler Group
California
-$43 -300 -5%

HGEN Hedge Fund Activity: Q4 2022 in Review

48 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q4 2022, worth a combined $858K — down 36% from $1.34M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of HGEN and 6 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 13 added.

The largest buyer was Renaissance Technologies, adding an estimated $90.3K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $185K sold.

  • 48 institutional investors held HUMANIGEN, INC. (HGEN) as of Q4 2022, down from 53 in Q3 2022.
  • Funds reported $858K of HUMANIGEN, INC. stock for Q4 2022, down 36% quarter-over-quarter.
  • 6 funds opened new HUMANIGEN, INC. positions in Q4 2022 and 10 closed out, a net change of -4 holders.
  • The largest HUMANIGEN, INC. buyer in Q4 2022 was Renaissance Technologies, an estimated $90.3K added.
  • The largest HUMANIGEN, INC. seller in Q4 2022 was GSA Capital Partners, an estimated $185K sold.

Based on aggregated 13F filings for Q4 2022.